Erratum: Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma (Theranostics (2019) 9:26 (8377-8391) DOI: 10.7150/thno.37628)

Abstract

The authors regret that the original version of our paper unfortunately contained some incorrect representative images. The EdU images of AZ505 groups in Figure 2Ca and the invasion image of siSMYD2 in Figure 2Da have been misused during figure assembly. The correct version of the Figure 2 appears below. The authors confirm that the corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that the errors may have caused.